Elon Musk’s brain-implant startup received approval from the Food and Drug Administration to conduct clinical trials of its experimental device in humans.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” Neuralink said Thursday in a tweet. Neuralink continued, “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.” We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our… — Neuralink (@neuralink) May 25, 2023 Musk retweeted the post, congratulating Neuralink. Congratulations Neuralink team! https://t.co/AWZGf33UDr — Elon Musk (@elonmusk) May […]
Read the rest of this story here: www.zerohedge.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
